Camber Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $76.4M | Sell |
|
|||||
|
2024
Q4 | $144M | Sell |
|
|||||
|
2024
Q3 | $130M | Hold |
|
|||||
|
2024
Q2 | $107M | Sell |
|
|||||
|
2024
Q1 | $116M | Hold |
|
|||||
|
2023
Q4 | $110M | Buy |
|
|||||
|
2023
Q3 | $76.2M | Buy |
|
|||||
|
2023
Q2 | $102M | Hold |
|
|||||
|
2023
Q1 | $121M | Sell |
|
|||||
|
2022
Q4 | $105M | Buy |
|
|||||
|
2022
Q3 | $123M | Hold |
|
|||||
|
2022
Q2 | $98.1M | Buy |
|
|||||
|
2022
Q1 | $65.3M | Buy |
|
|||||
|
2021
Q4 | $29.9M | Hold |
|
|||||
|
2021
Q3 | $27.9M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $9.16M | Sell |
|
|||||
|
2017
Q1 | $12.3M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $28M | Buy |
|
|||||
|
2016
Q2 | $10.5M | Buy |
|
|||||
|
2016
Q1 | $5.76M | Buy |
|
|||||
|
2015
Q4 | $16.2M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $27.2M | Buy |
|
|||||
|
2014
Q3 | $6.96M | Buy |
|